Shroom Shmooz
With MDMA-Assisted Therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) highly anticipated to become the first Schedule 1 psychedelic-based therapy to be federally legalized in the US by 2Q24, once approved, affordability becomes the key condition for mainstreaming the use of the therapy. Progress toward a more robust payor coverage for and broader-based accessibility to psychedelic-assisted therapies (PATs) has taken a major step forward with the recent approval by the American Medical Association (AMA) for the assignment of the first-of-its kind Current Procedural Terminology (CPT) code, an insurance billing code for long-form PAT...
Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.
Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.
Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.